在大肠杆菌中多种药物排泄基因acrAB的表达:系统性审查和元分析
Saleh Salem Bahaj1, Mohammed Saleh Al-Dhubaibi2, Aref Noman3
1Department of Microbiology and Immunology, Faculty of Medicine and Health Sciences, Sana'a University, Sana'a, Yemen. salehbahaj2025@gmail.com.
BMC infectious diseases
|October 22, 2025
概括
耐多药性大肠杆菌 (大肠杆菌) 过度表达了AcrAB-TolC排泄,增加了抗生素耐药性. 排泄抑制剂 (EPI) 在恢复抗生素敏感性方面表现有前途,但临床使用面临挑战.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多抗药性大肠杆菌 (E. coli) 构成了严重的公共卫生威胁.
- 溢出的过度表达,特别是AcrAB-TolC,是驱动大肠杆菌中MDR的主要机制.
- 这些排泄系统对关键的抗生素类别,如诺基诺,β-乳酸盐和氨基糖化物产生抗性.
研究的目的:
- 系统地审查和对E. coli中AcrAB-TolC排泄表达的现有数据进行元分析.
- 评估排泄抑制剂 (EPI) 在逆转抗生素耐药性的有效性.
- 巩固关于AcrAB-TolC表达模式及其对抗菌素敏感性的影响的证据.
主要方法:
- 在主要的科学数据库 (PubMed,Scopus,Google Scholar,EBSCO) 进行系统的文献搜索.
- 包括实验研究量化acrAB表达 (qPCR,RNA-seq,微阵列) 和评估EPI疗效.
- 通过随机效应元分析进行数据合成,并使用I2统计数据进行异质性评估.
主要成果:
- 对10项研究的综合分析显示,MDR大肠杆菌分离物中的acrAB表达显著升高 (SMD:3.5).
- 排泄的抑制导致诺基诺和β-乳酸的最小抑制度 (MIC) 显著降低 (≥4倍).
- EPI显示出恢复抗生素敏感性的显著能力 (RR:4.2),尽管研究异质性明显.
结论:
- 过度表达AcrAB-TolC是大肠杆菌抗生素耐药性的关键驱动因素.
- 排泄抑制是对抗MDR大肠杆菌感染的一种有前途的治疗策略.
- 需要进一步的研究来开发更安全的EPI,并优化临床应用的组合疗法.
相关概念视频
ABC Transporters: Exporter
6.3K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
6.3K
Stringent Response in E. coli
292
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
292
Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Carrier-Mediated Transport
1.1K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.1K


